Drugs / Ganoderma lucidum spore
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02844114 | Jan 2016 → Jan 2018 | non-small cell lung carcinoma | Gao Yajie | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ganoderma lucidum spore | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02844114 ↗ |
| Route | Oral | “Ganoderma lucidum spore 1500mg tablet by mouth, every 8 hours for 7 days” NCT02844114 ↗ |